Free Trial

ARS Pharmaceuticals (SPRY) Insider Trading & Ownership

ARS Pharmaceuticals logo
$8.74 -0.26 (-2.89%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$8.60 -0.14 (-1.60%)
As of 05/8/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$21.31M
Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SPRY Insider Buying and Selling by Quarter

ARS Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2025Sell21,828$8.71$190,121.88  
11/12/2025Sell166,380$8.87$1,475,790.60  
8/21/2025Sell12,500$15.00$187,500.00  
8/21/2025Sell50,000$14.49$724,500.00  
8/20/2025Sell37,656$14.09$530,573.04  
8/19/2025Sell12,344$14.03$173,186.32  
7/1/2025
Eric Karas
Insider
Sell15,000$16.99$254,850.00  
6/27/2025
James E Flynn
Major Shareholder
Sell740,149$18.46$13,663,150.54  
6/18/2025
Eric Karas
Insider
Sell15,000$16.00$240,000.00  
5/20/2025Sell102,969$14.10$1,451,862.90  
5/20/2025Sell120,000$14.25$1,710,000.00  
5/20/2025Sell50,000$14.10$705,000.00  
(Data available from 1/1/2013 forward)

SPRY Insider Trading Activity - Frequently Asked Questions

33.50% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings.

The following insiders have sold SPRY shares in the last 24 months: Alexander A Fitzpatrick ($1,451,862.90), Brent L. Saunders ($1,710,000.00), Brian Dorsey ($1,247,621.88), Eric Karas ($914,850.00), James E Flynn ($23,196,496.78), Justin Chakma ($3,928,886.92), Kathleen D Scott ($1,292,500.00), Laura Shawver ($3,863,284.24), Peter A Thompson ($7,522,032.00), Richard E Lowenthal ($6,127,322.35), and Sarina Tanimoto ($7,372,976.99).

Insiders have sold a total of 4,054,881 ARS Pharmaceuticals shares in the last 24 months for a total of $58,627,834.06 sold.



This page (NASDAQ:SPRY) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners